Table 2.
Patients With a Hip Fracture, %
|
||||
---|---|---|---|---|
Men
|
Women
|
|||
1986–1988 (n = 22 941) | 2003–2005 (n = 28 097) | 1986–1988 (n = 83 541) | 2003–2005 (n = 84620) | |
Acute or old myocardial infarction | 4.5 | 13.1 | 3.4 | 9.2 |
| ||||
Cancer and metastatic carcinoma | 8.1 | 13.6 | 3.9 | 6.2 |
| ||||
Cerebrovascular disease | 13.3 | 12.4b | 10.6 | 10.8c |
| ||||
Chronic pulmonary disease | 23.1 | 34.3 | 9.6 | 24.2 |
| ||||
Chronic renal failure | 3.3 | 9.0 | 1.2 | 4.1 |
| ||||
Congestive heart failure | 13.5 | 29.0 | 12.5 | 25.2 |
| ||||
Dementia | 6.3 | 7.7 | 7.0 | 8.4 |
| ||||
Diabetes with or without sequelae | 9.6 | 25.0 | 9.8 | 19.8 |
| ||||
Moderate or severe liver disease | 0.2 | 0.3b | 0.5 | 0.8 |
| ||||
Paralysis | 3.1 | 1.6 | 2.0 | 1.3 |
| ||||
Peripheral vascular disease | 3.5 | 10.7 | 1.9 | 6.5 |
| ||||
Rheumatologic disease | 1.3 | 2.2 | 1.2 | 3.9 |
| ||||
Ulcer disease | 2.8 | 3.7 | 1.8 | 3.0 |
| ||||
Chronic liver disease/cirrhosis | 0.4 | 0.7 | 0.2 | 0.5 |
All differences across time are statistically significant at the P <.001 level except as noted. Based on 20% sample of Medicare claims. Comorbid conditions are defined using the Klabunde adaptation of the Charlson score.
Denotes statistical significance at P <.01.
Denotes P=.09.